| 제목 | Subject | [July 2026 Update] China NMPA Enforces New Regulations for Cosmetic Ingredient Registration | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 첨부파일 | Attachment | ||||||||
[July 2026 Update] China NMPA Enforces New Regulations for Cosmetic Ingredient RegistrationEffective July 15, 2026, China's National Medical Products Administration (NMPA) officially implemented the newly revised "Provisions on the Administration of New Cosmetic Ingredients Registration, Filing, and Data." Replacing the previous 2021 framework, this pivotal regulatory update introduces significantly stricter technical review processes and elevates the safety assessment standards required for introducing novel cosmetic ingredients into the Chinese market. This comprehensive update demands a higher caliber of scientific data from the initial R&D phase through to final approval. Cosmetic companies and ingredient suppliers must now provide exhaustive documentation detailing ingredient origins, manufacturing processes, impurity controls, and long-term toxicological safety. Furthermore, the NMPA has clarified the transitional management requirements for the revised Safety and Technical Standards for Cosmetics (STSC), which includes a strict prohibition on the use of mercury and its compounds effective July 1, 2026. For international beauty brands and raw material manufacturers aiming to leverage innovative formulations in China, these enforced regulations represent a critical compliance milestone. Inadequate data submission or a failure to align with the new guidelines can lead to immediate application rejections and costly market entry delays. It is imperative that brands engage with specialized NMPA regulatory consultants early in the product lifecycle to overhaul their ingredient registration strategies and secure necessary supplemental data through accredited Chinese testing facilities.
|
|||||||||